Algorithms for detecting significantly mutated pathways in cancer

  • Authors:
  • Fabio Vandin;Eli Upfal;Benjamin J. Raphael

  • Affiliations:
  • Dipartimento di Ingegneria dell'Informazione, Università di Padova, Padova, Italy;Department of Computer Science, Brown University, Providence, RI;Department of Computer Science, Brown University, Providence, RI

  • Venue:
  • RECOMB'10 Proceedings of the 14th Annual international conference on Research in Computational Molecular Biology
  • Year:
  • 2010

Quantified Score

Hi-index 0.00

Visualization

Abstract

Recent genome sequencing studies have shown that the somatic mutations that drive cancer development are distributed across a large number of genes This mutational heterogeneity complicates efforts to distinguish functional mutations from sporadic, passenger mutations Since cancer mutations are hypothesized to target a relatively small number of cellular signaling and regulatory pathways, a common approach is to assess whether known pathways are enriched for mutated genes However, restricting attention to known pathways will not reveal novel cancer genes or pathways An alterative strategy is to examine mutated genes in the context of genome-scale interaction networks that include both well characterized pathways and additional gene interactions measured through various approaches We introduce a computational framework for de novo identification of subnetworks in a large gene interaction network that are mutated in a significant number of patients This framework includes two major features First, we introduce a diffusion process on the interaction network to define a local neighborhood of “influence” for each mutated gene in the network Second, we derive a two-stage multiple hypothesis test to bound the false discovery rate (FDR) associated with the identified subnetworks We test these algorithms on a large human protein-protein interaction network using mutation data from two recent studies: glioblastoma samples from The Cancer Genome Atlas and lung adenocarcinoma samples from the Tumor Sequencing Project We successfully recover pathways that are known to be important in these cancers, such as the p53 pathway We also identify additional pathways, such as the Notch signaling pathway, that have been implicated in other cancers but not previously reported as mutated in these samples Our approach is the first, to our knowledge, to demonstrate a computationally efficient strategy for de novo identification of statistically significant mutated subnetworks We anticipate that our approach will find increasing use as cancer genome studies increase in size and scope.